Ozempic maker Novo Nordisk, after trial disappointment, …
2 days ago · Novo Nordisk said an agreement reached last year with privately held Lexington, Mass. company Valo Health that initially was valued at up to $2.7 billion is now been expanded to a $4.6 billion deal.
Ozempic maker Novo Nordisk, after trial disappointment, …
Novo Nordisk shares plunged 21% in late December when the company said its CagriSema drug, in a late-stage trial, results in 20.4% weight loss, a figure which came in below Wall Street expectations.
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk …
Nov 6, 2024 · Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the...
How Trump’s Greenland Plan Could Hit Ozempic, Legos and …
2 days ago · Novo Nordisk is increasing its U.S. production to meet the soaring demand for its GLP-1 weight loss products. The company does not specify publicly how much of its products are exported, but it ...
Novo Nordisk's Ozempic Wins Approval in Europe for Chronic …
Dec 20, 2024 · Ozempic (semaglutide) is now positioned to become the first GLP-1 (glucagon-like peptide 1) receptor agonist approved for reducing the risk of kidney disease advancement in adults with type 2...
Novo Nordisk Sinks on Disappointing Trial Results for Next Gen …
Dec 20, 2024 · Novo Nordisk's (NVO) U.S.-listed shares sank over 19% in premarket trading Friday after releasing trial results for its next generation of weight loss drug, meant to add to its current lineup...
Novo's Ozempic faces scrutiny over potential link to rare eye …
Dec 16, 2024 · A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over …
Dec 17, 2024 · There may be a new, unintended side effect linked to Novo Nordisk's blockbuster diabetes injection, Ozempic.
Novo Nordisk's Ozempic faces EU review for potential eye …
Dec 18, 2024 · The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes drug Ozempic to a rare eye disease.
Ozempic, Wegovy maker Novo Nordisk faces hearing over high …
Sep 24, 2024 · Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO testified on Capitol Hill Tuesday.